The efficacy and safety of thymosin alpha-1 combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a retrospective study

S Siyang Yao Q Qiangsong Huang Y Yan Zou (Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, State Key Laboratory of Molecular Engineering of Polymers, Department of Chemistry) T Tianqi Liu (School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University) Y Yongyu Yang T Tao Huang Y Yuanquan Zhao X Xiaofeng Dong

Article Details

Volume / Issue Vol. 15, Issue 1
Published April 22, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (8)

S

Siyang Yao

Q

Qiangsong Huang

Y

Yan Zou

Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, State Key Laboratory of Molecular Engineering of Polymers, Department of Chemistry

T

Tianqi Liu

School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University

Y

Yongyu Yang

T

Tao Huang

Y

Yuanquan Zhao

X

Xiaofeng Dong